Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minna Rahnasto-Rilla

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Chemical Information and Modeling|April 25, 2022
Expanding the Accessible Chemical Space of SIRT2 Inhibitors through Exploration of Binding Pocket DynamicsNemanja Djokovic, Dusan Ruzic, Minna Rahnasto-Rilla, et al.
Chemical Research in Toxicology|February 5, 2015
In silico prediction of the site of oxidation by cytochrome P450 3A4 that leads to the formation of the toxic metabolites of pyrrolizidine alkaloidsMuluneh M Fashe, Risto O Juvonen, Aleksanteri Petsalo, et al.
Current Drug Metabolism|April 14, 2012
Function and regulation of the Cyp2a5/CYP2A6 genes in response to toxic insults in the liverA'edah Abu-Bakar, Jukka Hakkola, Risto Juvonen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 17, 2012
Interactions of inhibitor molecules with the human CYP2E1 enzyme active siteLaura E Martikainen, Minna Rahnasto-Rilla, Silvie Neshybova, et al.
Chemical Research in Toxicology|October 9, 2014
Identification of a new reactive metabolite of pyrrolizidine alkaloid retrorsine: (3H-pyrrolizin-7-yl)methanolMuluneh M Fashe, Risto O Juvonen, Aleksanteri Petsalo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Peptides and Pseudopeptides as SIRT6 Deacetylation InhibitorsPiia Kokkonen, Minna Rahnasto-Rilla, Päivi H Kiviranta, et al.
Bioorganic & Medicinal Chemistry|December 3, 2014
Rational design of novel CYP2A6 inhibitorsNiina Tani, Risto O Juvonen, Hannu Raunio, et al.
European Journal of Medicinal Chemistry|November 22, 2011
Antifungal activities of novel non-azole molecules against S. cerevisiae and C. albicansNiina Tani, Minna Rahnasto-Rilla, Carsten Wittekindt, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2020
Effects of galloflavin and ellagic acid on sirtuin 6 and its anti-tumorigenic activitiesMinna Rahnasto-Rilla, Joni Järvenpää, Marjo Huovinen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 22, 2014
Quantitative insights for the design of substrate-based SIRT1 inhibitorsPiia Kokkonen, Paolo Mellini, Olli Nyrhilä, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Chemical Information and Modeling|April 25, 2022
Expanding the Accessible Chemical Space of SIRT2 Inhibitors through Exploration of Binding Pocket DynamicsNemanja Djokovic, Dusan Ruzic, Minna Rahnasto-Rilla, et al.
Chemical Research in Toxicology|February 5, 2015
In silico prediction of the site of oxidation by cytochrome P450 3A4 that leads to the formation of the toxic metabolites of pyrrolizidine alkaloidsMuluneh M Fashe, Risto O Juvonen, Aleksanteri Petsalo, et al.
Current Drug Metabolism|April 14, 2012
Function and regulation of the Cyp2a5/CYP2A6 genes in response to toxic insults in the liverA'edah Abu-Bakar, Jukka Hakkola, Risto Juvonen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 17, 2012
Interactions of inhibitor molecules with the human CYP2E1 enzyme active siteLaura E Martikainen, Minna Rahnasto-Rilla, Silvie Neshybova, et al.
Chemical Research in Toxicology|October 9, 2014
Identification of a new reactive metabolite of pyrrolizidine alkaloid retrorsine: (3H-pyrrolizin-7-yl)methanolMuluneh M Fashe, Risto O Juvonen, Aleksanteri Petsalo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Peptides and Pseudopeptides as SIRT6 Deacetylation InhibitorsPiia Kokkonen, Minna Rahnasto-Rilla, Päivi H Kiviranta, et al.
Bioorganic & Medicinal Chemistry|December 3, 2014
Rational design of novel CYP2A6 inhibitorsNiina Tani, Risto O Juvonen, Hannu Raunio, et al.
European Journal of Medicinal Chemistry|November 22, 2011
Antifungal activities of novel non-azole molecules against S. cerevisiae and C. albicansNiina Tani, Minna Rahnasto-Rilla, Carsten Wittekindt, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2020
Effects of galloflavin and ellagic acid on sirtuin 6 and its anti-tumorigenic activitiesMinna Rahnasto-Rilla, Joni Järvenpää, Marjo Huovinen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 22, 2014
Quantitative insights for the design of substrate-based SIRT1 inhibitorsPiia Kokkonen, Paolo Mellini, Olli Nyrhilä, et al.
Pageof 3